The cost of scleroderma treatment is determined by each region, the level of the hospital and the degree of the disease. Usually the cost is lower in the early stages of the disease and higher if the disease is in the middle or late stages and the condition is more severe. Scleroderma is a common immune system disease, also known as systemic sclerosis, clinically characterized by limited or diffuse skin thickening and fibrosis, which can affect the heart, lungs, digestive tract and other organs. The cost of scleroderma treatment is determined by the region, the level of the hospital and the degree of the disease, with different levels of consumption and different fees charged. Early in the disease, the cost of treatment is low, if the disease is in the middle and late stages, the condition is serious, there is no targeted specific drugs, mainly by maintaining the relief of symptoms, the cost of treatment is higher. It is recommended that patients should go to a regular hospital, identify the cause of the disease, and under the guidance of a professional doctor for treatment.